We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 29 APRIL 2016
Eli Lilly's Cialis® Patent Withstands Double Patenting And Utility Challenges On Appeal

Gowling WLG
Contributor

Gowling WLG
The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...
View firm profileThe Federal Court of Appeal has provided guidance on the law of obviousness-type double patenting in dismissing Mylan's appeal pertaining to Eli Lilly's Canadian Patent 2,226,784, covering Lilly's drug Cialis®.
CanadaIntellectual Property



